Founders at Work: TwoStep Therapeutics

​TwoStep Therapeutics is a biotechnology company developing a pipeline built around a versatile targeting peptide “PIP” that binds selectively to multiple tumor-associated integrins, a unique feature that enables it to deliver various payloads to virtually any solid tumor. The company leverages this technology to create targeted cancer therapies for drug delivery and radioligand therapy. TwoStep Therapeutics was co-founded by CEO, Caitlyn Miller, in collaboration with world-renowned academic entrepreneurs at Stanford University, including Nobel Laureate Carolyn Bertozzi, Jennifer Cochran, and Ronald Levy.

Come learn more about TwoStep Therapeutics, including an ‘ask me anything’-style Q&A at the end.